PMID: 1978947Oct 1, 1990Paper

Use of inhaled corticosteroids in patients with mild asthma

Thorax
S LorentzsonG Persson

Abstract

A double blind, parallel group study was carried out to investigate the effect of inhaled budesonide in a moderate (200 micrograms) and a low (100 micrograms) twice daily dosage compared with the effect of placebo in 103 adults with mild symptomatic asthma. Subjects recorded peak expiratory flow (PEF), asthma symptoms, and beta 2 agonist consumption at home for a period of seven weeks (a one week run in and six weeks' treatment). Morning baseline PEF (around 80% of predicted normal) increased non-significantly to 88% with 200 micrograms budesonide daily and to 90% (p less than 0.05) with 400 micrograms, compared with 81% with placebo. Evening PEF (around 94% of predicted normal) did not change significantly with active or placebo treatment. By comparison with placebo, there was a significant decrease in nocturnal asthma symptoms and beta 2 agonist consumption. The changes during the day were less pronounced and significant only for 400 micrograms budesonide daily. No significant differences between the two active treatments were detected. It is concluded that low doses of inhaled budesonide are effective in patients with mild symptomatic asthma, particularly for night time symptoms and early morning lung function. The early int...Continue Reading

References

Mar 1, 1987·New England and Regional Allergy Proceedings·H G Morris
Dec 1, 1985·The Journal of Allergy and Clinical Immunology·D P TashkinH Kerschnar
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·T J Clark
Jul 15, 1985·The American Journal of Medicine·E S Caplan, N J Hoyt
Aug 1, 1983·Postgraduate Medical Journal·B Hockley, N M Johnson
May 1, 1983·Allergy·P Tønnesen

Citations

Feb 1, 1995·The American Journal of Medicine·N A HananiaS Kesten
Jan 11, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·S B BonalaA T Schneider
Jun 3, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J KempJ Grossman
Dec 17, 2005·Current Opinion in Pulmonary Medicine·P G Gibson, H Powell
Jan 1, 1997·British Journal of Clinical Pharmacology·C A OborneS H Jackson
Mar 1, 1997·Respirology : Official Journal of the Asian Pacific Society of Respirology·B Zainudin
Jul 9, 1998·American Journal of Respiratory and Critical Care Medicine·T van der MolenD S Postma
Mar 1, 1992·The American Review of Respiratory Disease·R DjukanovićS T Holgate
Oct 1, 1993·The American Review of Respiratory Disease·P J Barnes, S Pedersen
Dec 28, 1999·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·S G KelsenW H Anderson
Feb 24, 2005·Annals of Emergency Medicine·Adam J SingerBrian O'Neil
Sep 1, 1992·The Journal of Allergy and Clinical Immunology·J B WempeG H Koëter
Aug 8, 1997·Biochemical and Biophysical Research Communications·K ShindoM Fukumura
Aug 6, 1998·Respiratory Medicine·S L ChisholmH Petri
Mar 13, 1998·The Annals of Pharmacotherapy·H W Kelly
Mar 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K ShindoK Koide
Oct 26, 1991·BMJ : British Medical Journal
Apr 24, 2004·The Cochrane Database of Systematic Reviews·H Powell, P G Gibson
Dec 1, 1991·Scandinavian Journal of Primary Health Care·H Melbye
Nov 1, 2001·The Cochrane Database of Systematic Reviews·N AdamsP W Jones
Apr 1, 1992·The Annals of Pharmacotherapy·R H JoeT Self

Related Concepts

Inhalation of Drugs
Administration, Topical
Adrenergic beta-Agonists
Anti-Inflammatory Agents
Asthma
Double-Blind Method
Polychemotherapy
Glucocorticoid Effect
Peak Expiratory Flow Rate Measurement
Pregnenediones

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.